• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

VIDEO: Susan Urba, MD, Discusses Chemotherapy-Induced Nausea and Vomiting

Article

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that treatment-related factors used to stratify patients to prevent chemotherapy-induced nausea and vomiting are the actual chemotherapy drugs.

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that treatment-related factors used to stratify patients to prevent chemotherapy-induced nausea and vomiting are the actual chemotherapy drugs. Dr Urba says that there are specific lists of medications that breakdown the medications into categories, such as highly emetogenic and moderately emetogenic. Dr Urba uses the medication cisplatin as an example of one of the widely used, highly emetogenic treatments used.

This video was taken on November 9 at the NAMCP Fall Managed Care Forum in Las Vegas, NV.

Related Videos
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.